PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAE4. A total of 15 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $26,678,000 | +5.4% | 17,710,000 | 0.0% | 0.52% | -1.7% |
| Q3 2014 | $25,302,000 | -20.6% | 17,710,000 | 0.0% | 0.53% | -24.4% |
| Q2 2014 | $31,877,000 | +16.6% | 17,710,000 | 0.0% | 0.70% | +19.3% |
| Q1 2014 | $27,332,000 | +0.1% | 17,710,000 | 0.0% | 0.58% | +8.3% |
| Q4 2013 | $27,295,000 | +7.2% | 17,710,000 | 0.0% | 0.54% | -4.8% |
| Q3 2013 | $25,466,000 | +25.7% | 17,710,000 | +20.0% | 0.57% | +9.5% |
| Q2 2013 | $20,254,000 | – | 14,762,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 25,974,000 | $40,197,000 | 19.49% |
| WOLVERINE ASSET MANAGEMENT LLC | 17,710,000 | $27,332,000 | 0.58% |
| UBS AG | 2,700,000 | $4,161,000 | 0.00% |
| DEUTSCHE BANK AG\ | 475,000 | $731,000 | 0.00% |
| Jefferies Group LLC | 52,000 | $80,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,400,000 | $2,158,000 | 0.00% |